Recent studies have showcased advancements in predicting cardiovascular disease risks, particularly among women. A new blood test developed by researchers at Brigham and Women's Hospital can forecast a woman's cardiovascular disease risk for up to 30 years by measuring C-reactive protein and two types of fat in the bloodstream. This research, backed by the National Institutes of Health, involved over 27,000 participants and revealed that combining these biomarkers enhances risk assessment significantly. Another study from the University of Leeds demonstrates that an AI tool named OPTIMISE identifies over 400,000 individuals at high risk of heart-related deaths by analyzing health records, leading to better management of undiagnosed conditions. Both studies highlight the need for comprehensive screening and personalized treatment strategies to mitigate heart disease risks effectively. These findings are expected to improve early detection and management of cardiovascular conditions, potentially saving lives.